Is tigecycline a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia?

Journal of Chemotherapy

Volumn 23, Issue 6, 2011, Pages 345-349

  Tasbakan, M S ^a   Pullukcu, H ^a   Sipahf, O R ^a   Tasbakan, M I ^a   Aydemir, S ^a   Bacakoglu, F ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

A. baumannii; Multidrug resistant; Pneumonia; Tigecycline

Indexed keywords

AMIKACIN; C REACTIVE PROTEIN; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; TIGECYCLINE; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MINOCYCLINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APACHE; ARTICLE; COMORBIDITY; DISK DIFFUSION; FEMALE; HOSPITALIZATION; HUMAN; HYPERTRANSAMINASEMIA; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MORTALITY; PNEUMONIA; RETROSPECTIVE STUDY; TRACHEAL ASPIRATION PROCEDURE; BACTERIAL PNEUMONIA; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MINOCYCLINE; PNEUMONIA, BACTERIAL; RETROSPECTIVE STUDIES;

EID: 84864928200     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/joc.2011.23.6.345     Document Type: Article

References (16)

1. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10): 3471-84
2. Alp E, Yerer M, Kocagoz S, Metan G, Esel O, Gurol Y, et al. The risk factors and spread of multidrug-resistant Acinetobacter baumannii in intubated patients in a medical intensive care unit. Turk J Med Sci 2009; 39: 761-769
3. Tasbakan MS, Pullukcu H, Ekren PK, Oz AT, Midilli M, Aydemir S, et al. Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii. Mikrobiyol Bul. 2009;43(1):61-70
4. Pankey G.A. Tigecycline. J Antimicrob Chemother. 2005; 56, 470-80.
5. Curcio O, Fernandez F, Cane A, Barcelona L, Stamboulian D. Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry. Braz J Infect Dis. 2008; 12, 198-201.
6. American Thoracic Society: Hospital-acquired, Ventilator-associated and Healthcare- associated Pneumonia. Am J Respir Crit Care Med. 2005;171,388-416.
7. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing, 15th Information Supplement, Document M100-A15, CLSI, Wayne, Pa, 2005.
8. Curcio O, Fernandez F, Duret F. Initial use of tigecycline in Argentina. Rev. Chilena Infectol. 2007;24,497-499.
9. Falagas ME, Metaxas EI. Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization. Expert Rev Anti Infect Ther. 2009;7(8):913-23.
10. Freire AT, Melnyk V, Kim MJ, Datsenko O, Dzyublik O, Glumcher F, et al Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia. Diagn Microbiolinfect Dis. 2010; 68(2): 140-51.
11. Schafer JJ, Goff DA, Stevenson KB, Mangino JE. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrugresistant Acinetobacter baumannii. Pharmacotherapy. 2007; 27, 980-987.
12. Gordon NC, Wareham OW. A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline. J Antimicrob Chemother. 2009;63(4): 775-80.
13. Curcio O, Castagnino J, Vazquez W, Vergara G, Curiale A; Latin American Tigecycline Use Registry for Ventilator Associated Pneumonia (LatinVAP). Tigecycline in the treatment of ventilator-associated pneumonia: experience from the Latin American Tigecycline Use Registry. Infez Med. 2010; 18(1):27-34
14. Curcio O, Fernandez F, Vergara J, Vazquez W, Luna CM. Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline. J Chemother 2009; 21: 58-62.
15. Karageorgopoulos O, Kelesidis T, Kelesidis I, Falagas ME. Tigecycline for the treatment of multidrug-resistant (including carbapenem resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother. 2008; 62: 45-55.
16. Poulakou G, Kontopidou FV, Paramythiotou E. Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens. J Infect 2009;58: 273-284.